US Patent Litigations are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Ter Meer Steinmeister & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Ter Meer Steinmeister & Partner

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3506931Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYApr 29, 2025LUIGI
EP4054620Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 27, 2025GENERICS UK
EP3889181Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 24, 2025LUIGI
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025RUMI
EP3150200Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 10, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB
EP3302996Security Element Having A Color-Shifting EffectHUECK FOLIEN GESELLSCHAFTJan 10, 2025GIESECKEDEVRIENT CURRENCY TECHNOLOGY
EP3328416Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024SANDOZ
EP3506915Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic DisordersPLAS FREEDec 5, 2024BIOTEST
EP3110848Methods For Treating Skin Infection By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYNov 14, 2024LUIGI
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024HOLLATZ